Ashurst, led by corporate partner Stephen Lloyd, advised Nomura as leader of a £25m investment in UK-based biotechnology company Chroma Therapeutics. Wragge & Co, led by corporate associate Ian Piggin, advised Chroma Therapeutics.
Taylor Wessing, led by intellectual property (IP) partner Malcolm Bates, has advised Marseille-based biotechnology company Innate Pharma on its partnership with Danish global healthcare company Novo Nordisk, which will see Novo Nordisk invest 10m (£6.9m) into the French firm. Kramer Levin Naftalis & Frankel, led by New York-based IP partner Paul Connuck, advised Novo Nordisk.
